Artwork

Konten disediakan oleh Ketamine Wellness Centers. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Ketamine Wellness Centers atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
Player FM - Aplikasi Podcast
Offline dengan aplikasi Player FM !

A Closer Look at Spravato (Esketamine) - What will the drug cost and will insurance cover it?

11:05
 
Bagikan
 

Manage episode 229190432 series 1756689
Konten disediakan oleh Ketamine Wellness Centers. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Ketamine Wellness Centers atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
As the P.R. machine kicks into gear to support the launch of Spravato/Esketamine, the first FDA approved Ketamine-derived treatment, Kevin Nicholson (President, CEO of Ketamine Wellness Centers) digs into the details that tend to receive less attention. This episode focuses on the cost of Spravato to the provide, end user, and insurer: - What are the preliminary cost estimates for Spravato (wholesale) - Can we estimate the cost to the patient? - Will insurance cover the drug? - How will the treatment schedule effect the cost? www.ketaminewellnesscenters.com/category/podcast/
  continue reading

15 episode

Artwork
iconBagikan
 
Manage episode 229190432 series 1756689
Konten disediakan oleh Ketamine Wellness Centers. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Ketamine Wellness Centers atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
As the P.R. machine kicks into gear to support the launch of Spravato/Esketamine, the first FDA approved Ketamine-derived treatment, Kevin Nicholson (President, CEO of Ketamine Wellness Centers) digs into the details that tend to receive less attention. This episode focuses on the cost of Spravato to the provide, end user, and insurer: - What are the preliminary cost estimates for Spravato (wholesale) - Can we estimate the cost to the patient? - Will insurance cover the drug? - How will the treatment schedule effect the cost? www.ketaminewellnesscenters.com/category/podcast/
  continue reading

15 episode

Semua episode

×
 
Loading …

Selamat datang di Player FM!

Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.

 

Panduan Referensi Cepat